LATTICE MEDICAL is an implantable medical device company that develops and manufactures a breakthrough resorbable implant supporting reconstruction with one’s own body fat (autologous fat reconstruction). The company has about 20 employees and a 3D printing production site dedicated to implantable medical devices. The first application of its technology is for breast reconstruction after cancer.
- Invested amount
EUR 1 499 954.56
“The EIC Fund process for our series A was a real opportunity to share, discuss and build a roadmap with our lead investors in the next steps of Lattice Medical. The process is fluid, the person chosen for the due diligence was smart with good questions and interrogations and we have concluded the deal in 8 months.”
Julien Payen, CEO